Dr. Delsignore has represented numerous clients in patent matters, including Boehringer Ingelheim, West-Ward Pharmaceuticals International Limited, Concert Pharmaceuticals, Inc., IBM, Hanmi Pharmaceutical Co., Limited, and Teva Pharmaceuticals. Her recent client work includes:
- Strategies for leveraging federal district court litigation and post patent issue proceedings in the United States Patent and Trademark Office Patent Trial and Appeal Board
- Freedom to operate strategies related to the launch of FDA approved drugs
- Evaluation of the intellectual property portfolios of target companies in due diligence studies
- Patent procurement and portfolio management for academic institutions
Dr. Delsignore is a member of the American Intellectual Property Law Association, the PTAB Bar Association, New York Intellectual Property Law Association and New Jersey Intellectual Property Law Association and is a member of the nominating committee for award of the Jefferson Medal. Dr. Delsignore is co-chair of the New York City Bar Association committee on Science and the Law, and is a member of the New York City Bar Association committee on Drugs and the Law.
Prior to joining Goodwin, Dr. Delsignore was head of the Chemical/Pharmaceutical/Biotechnology patent group at Pitney, Hardin Kipp & Szuch, and practiced patent law in the intellectual property group of Baker Botts L.L.P. and in the intellectual property firm of Brumbaugh, Graves, Donohue & Raymond.